AGP Executive Report
Last update: 12 hours agoVape Policy Push: Malaysia’s health minister cited 402 vape cases tied to synthetic drugs, arguing the findings strengthen the case for a vape ban—especially for minors. Cultivation Innovation: Arizona’s Aeriz is expanding aeroponic, soil-free cannabis growing that claims major water savings and faster plant growth. Medical Research: University of Arizona scientists report cannabis terpenes may ease chronic pain (fibromyalgia, post-surgical) without THC-style intoxication, while another study found fentanyl is seldom added to illicit cannabis flower. Regulation Watch: Virginia lawmakers struck a budget deal that adds a data-center energy fee and also sets up a regulated retail cannabis market timeline. Market & Safety Debate: A new review says decriminalization or tightly controlled access doesn’t boost overall use, but commercialized legal markets may raise potency and health risks, including addiction and psychosis admissions. Retail/Compliance: Minnesota cannabis testing-site closures are causing product delays for retailers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Cannabis in Oncology Nursing: Reducing Polypharmacy and Managing Symptoms]]>](https://cdn.sanity.io/images/0vv8moc6/oncnurse/fd0ace1d084f9b0aef0c98a08b0a7fb98027f032-1920x1080.jpg)
